DrArunashis Sau

Dr Arunashis Sau is a Clinical Academic at the National Heart & Lung Institute, Imperial College London, his main reseearch interests are applying AI for addressing challenges in cardiovascular and heart rhythm care. He was recently awarded a prestiguous British Heart Foundation Clinical Future Leader's Fellowship, which funds his work on a multimodal AI platform for arrhythmia care. 

Dr Sau developed the AIRE (AI-ECG Risk Estimation) platform, with publications in Lancet Digital Health, JAMA Cardiology and European Heart Journal. He co-founded Cardiovolt.ai Limited to translate this work into a regulated medical device. His work on AI-ECG risk prediction has been awarded multiple awards, including first prize at young investigator awards BCS 2023, HRC 2023, BHRS 2024, e-Cardiology awards EHRA 2022 & 2024 and RSM President's prize 2024. As a clinician-computer scientist, Dr Sau has personally designed and developed the deep learning models underlying his research. Clinically Dr Sau is a cardiologist and cardiac electrophysiologist with expertise in ablation and complex devices. 

He studied medicine at Imperial College London, where he was awarded a First Class (Hon) BSc degree in Medical Sciences with Cardiovascular sciences and Distinctions in Medical Sciences, Clinical Science and Clinical Practice. He has been awarded a Postgraduate Certificate in Medical Education by the University of Dundee. His postgraduate clinical training to date has been in the North West Thames deanery, firstly as an NIHR Academic Clinical Fellow. In 2021, Dr. Sau was awarded a British Heart Foundation Clinical Research Training Fellowship during which he developed his interest in cardiovascular data science and AI. He continued his post doctoral and clinical training as an NIHR Academic Clinical Lecturer, before being awarded the BHF Clinical Future Leader's Fellowship.